Mirae Asset Global ETFs Holdings’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,015
Closed -$22.3K – 3296
2026
Q1
$22.3K Buy
6,015
+176
+3% +$739 ﹤0.01% 3035
2025
Q4
$20.1K Buy
5,839
+176
+3% +$702 ﹤0.01% 3049
2025
Q3
$28.9K Sell
5,663
-9,394
-62% -$49K ﹤0.01% 3025
2025
Q2
$79.7K Sell
15,057
-157
-1% -$1.14K ﹤0.01% 2716
2025
Q1
$124K Buy
15,214
+624
+4% +$5.83K ﹤0.01% 2533
2024
Q4
$187K Buy
14,590
+608
+4% +$7.17K ﹤0.01% 2415
2024
Q3
$150K Buy
13,982
+966
+7% +$9.07K ﹤0.01% 2515
2024
Q2
$103K Buy
+13,016
New +$124K ﹤0.01% 2549

Other funds holding RCEL

Mirae Asset Global ETFs Holdings's RCEL Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Avita Medical (RCEL) in Q2 2026, closing a stake of 6,015 shares — an estimated $22.3K sold.

Mirae Asset Global ETFs Holdings first reported a position in RCEL in Q2 2024 and held it in 8 quarters. The position peaked at $187K in Q4 2024. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Avita Medical position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 6,015 Avita Medical shares in Q2 2026, an estimated $22.3K.
  • Mirae Asset Global ETFs Holdings first reported a position in Avita Medical in Q2 2024 and held it in 8 quarters.
  • Mirae Asset Global ETFs Holdings's Avita Medical position peaked at $187K in Q4 2024.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.